Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and ...

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...

The independent judiciary that America enjoys is rare in the history of mankind and among all nations of the earth even at ...

According to recent lawsuits, the deal has become highly controversial. Critics argue that the transfer of valuable land to a sitting president for less than its true worth, in hopes of reported ...

Picture the scenario: an unsigned artist — no label, no marketing budget, no A&R returning their calls — opens an email announcing that a major AI company will pay them tens of thousands of dollars to ...

Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease June 29, 2026 8:00 ...

Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced new interim data from its ongoing open-label Phase 1/2 first-in-human study of EPI-321 in ...

The New York Knicks have restored the feeling. So here's the 100 best New York City rap songs of all time, with classics from ...

Blair Jackson says the next 12 months may be the most important in Alkermes’ history, as the brain drugmaker races to join an ...

Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction June 24, ...

Costco's $4.99 Rotisserie Chicken Is at the Center of a Heated Legal Battle Over What "No Preservatives" Actually Means It ...